Almotriptan reduces the incidence of migraine-associated symptoms: A pooled analysis

Headache

Volumn 42, Issue SUPPL. 1, 2002, Pages 26-31

  Cady, Roger ^a  

^a Primary Care Network   (United States)

Author keywords

Almotriptan; Migraine; Nausea; Phonophobia; Photophobia; Sumatriptan; Vomiting

Indexed keywords

ALMOTRIPTAN; SUMATRIPTAN;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; NAUSEA; PAIN ASSESSMENT; PHOTOPHOBIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

EID: 0036166349     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.0420s1026.x     Document Type: Conference Paper

References (17)

1. The burden of migraine to the individual sufferer: A review
2. Migraine symptoms: Results of a survey of self-reported migraineurs
3. Acute management of migraine: Triptans and beyond
4. Antimigraine drugs
5. New triptan preparations can help the migraine patient. Pharmacodynamic and pharmacokinetic progresses
6. Management of migraine: An algorithmic approach
7. 1B/1D agonists: Insights into migraine pathophysiology using rizatriptan
8. Ergotamine in the acute treatment of migraine: A review and European consensus
9. Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine
10. Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: Results of a large, randomized, double-blind, placebo-controlled study
11. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: A double-blind, randomized, parallel-group, optimum-dose comparison
12. Acute migraine therapy: Do doctors understand what patients with migraine want from therapy?
13. Determinants of patient satisfaction with migraine therapy
14. An assessment of the burden of migraine using the willingness to pay model
15. Acute migraine treatment: Factors affecting therapeutic decision making
16. Almotriptan is an effective and well-tolerated treatment for migraine pain: Results of a randomised, double-blind, placebo-controlled clinical trial
17. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain